Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis.

Clinical Science
Lei ZhangXiao-Jing Zhang

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the fastest growing chronic liver disease, with a prevalence of up to 25% worldwide. Individuals with NAFLD have a high risk of disease progression to cirrhosis, hepatocellular carcinoma (HCC), and liver failure. With the exception of intrahepatic burden, cardiovascular disease (CVD) and especially atherosclerosis (AS) are common complications of NAFLD. Furthermore, CVD is a major cause of death in NAFLD patients. Additionally, AS is a metabolic disorder highly associated with NAFLD, and individual NAFLD pathologies can greatly increase the risk of AS. It is increasingly clear that AS-associated endothelial cell damage, inflammatory cell activation, and smooth muscle cell proliferation are extensively impacted by NAFLD-induced systematic dyslipidemia, inflammation, oxidative stress, the production of hepatokines, and coagulations. In clinical trials, drug candidates for NAFLD management have displayed promising effects for the treatment of AS. In this review, we summarize the key molecular events and cellular factors contributing to the metabolic burden induced by NAFLD on AS, and discuss therapeutic strategies for the improvement of AS in individuals with NAFLD.

References

Jul 1, 1994·The Journal of Clinical Investigation·A DaughertyJ W Heinecke
Mar 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·P ProvostD Waters
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·E M GordonF L Hall
Sep 18, 1998·Biochimica Et Biophysica Acta·C H HeldinL Rönnstrand
May 29, 1999·Gastroenterology·C A MatteoniA J McCullough
May 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·H C Stary
Aug 10, 2000·Drugs·P H Chong, B S Bachenheimer
Dec 21, 2000·American Journal of Physiology. Cell Physiology·P RocicP A Lucchesi
Oct 9, 2002·Mini Reviews in Medicinal Chemistry·E A Rekka, M C Chrysselis
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Josiah N WilcoxJuan Casanova
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yong-Han PaikDavid A Brenner
May 4, 2004·Biochemical and Biophysical Research Communications·Sungwoo RyooKwang-Lae Hoe
May 19, 2004·Hypertension·Ishwarlal JialalSenthil K Venugopal
Sep 7, 2004·Free Radical Research·Fanny RobbesynAnne Negre-Salvayre
Sep 18, 2004·Metabolism: Clinical and Experimental·Michael J HaasArshag D Mooradian
Dec 14, 2004·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Zhiguo LiuZechun Zhao
Jan 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Caius G RaduOwen N Witte
Nov 22, 2005·Journal of Lipid Research·Jason M RidlonPhillip B Hylemon
Nov 9, 2006·Journal of Lipid Research·Britta LoefflerMartin Merkel

❮ Previous
Next ❯

Citations

Feb 4, 2021·Journal of Clinical Medicine·David NiederseerChristian Datz
Mar 16, 2021·Frontiers in Medicine·Anna Pia Delli BoviPietro Vajro
Aug 28, 2021·Frontiers in Nutrition·Eric C Westman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Journal of Clinical and Translational Hepatology
Ramesh KumarUtpal Anand
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Philipp KasperHans-Michael Steffen
Current Pharmaceutical Design
Hideyuki HyogoSho-Ichi Yamagishi
Journal of Lifestyle Medicine
Ki Bae Bang, Yong Kyun Cho
© 2021 Meta ULC. All rights reserved